How Is the Indomethacin Trial Done for Hemicrania Continua?

The diagnostic trial for hemicrania continua involves a clinician-supervised trial of indomethacin, a powerful nonsteroidal anti-inflammatory drug (NSAID). Because hemicrania continua is defined by an absolute, complete response to indomethacin ^[1], doctors use this structured trial to see if the medication entirely abolishes both the continuous background pain and the severe pain spikes ^[2].

While some clinics administer a supervised injection (often called the “Indotest”), most patients undergo an outpatient oral trial. There is no single universal schedule for the oral trial, as protocols vary slightly between headache centers ^[3]. However, it always involves a supervised, step-by-step approach that balances finding the effective dose against preventing side effects ^[4].

A complete response strongly supports the diagnosis, but it does not replace a full neurological evaluation. Your doctor will still evaluate your medical history and may order imaging to rule out secondary causes, especially if you have “red flag” symptoms like sudden-onset pain, fever, or new weakness.

The Stepwise Oral Trial Protocol

To confirm the diagnosis, clinicians prescribe a gradual dose escalation—a process called titration. The goal is to find the lowest effective dose that completely stops the pain ^[5].

• Low Starting Dose: The trial typically begins at a low oral dose (for example, 25 mg two or three times daily for adults). This helps identify if you are particularly sensitive to the drug’s side effects.
• Gradual Titration: If the headache does not fully resolve, the doctor will direct you to slowly increase the dose every few days (for example, stepping up to 50 mg three times daily) ^[3]. (Note: These are adult examples, not a schedule to copy. Your prescriber will choose your exact dose and plan).
• The ICHD-3 Diagnostic Benchmark: The International Classification of Headache Disorders (ICHD-3) notes that for adults, confirming a true “non-response” may require reaching a dose of at least 150 mg daily, and sometimes up to 225 mg daily. However, this is a diagnostic reference, not a mandatory target. A doctor may stop the trial at a lower dose due to side effects, or a complete response may happen at a lower dose. You should never force your way to a high dose if you are experiencing toxicity.
• Response Timing: If you have hemicrania continua, relief is often rapid once you reach your effective dose. Some case reports show marked relief within 8 to 24 hours of hitting the right threshold ^[6][7]. However, timing varies significantly by individual, and an adequate trial may take several days to a few weeks depending on how slowly the dose is increased. A slow response does not automatically rule out the condition.

Partial relief does not satisfy the strict diagnostic criteria for hemicrania continua; the response must be complete ^[8].

Baseline Risk Review

Indomethacin carries a higher risk of side effects than over-the-counter pain relievers ^[4]. Before starting a trial, your doctor must review your complete medical history. You must disclose if you have:

• A history of stomach ulcers or gastrointestinal bleeding ^[4]
• Kidney disease, significant heart failure, or recent cardiovascular events ^[9]
• High blood pressure (hypertension) or asthma (particularly an aspirin/NSAID-sensitive breathing reaction) ^[10]
• Pregnancy or plans to conceive

You must also provide a complete list of all prescriptions, over-the-counter products, and supplements. Indomethacin can have dangerous interactions with blood thinners (like warfarin or direct oral anticoagulants), antiplatelets (like clopidogrel or aspirin), corticosteroids, lithium, methotrexate, certain antidepressants (SSRIs/SNRIs), and blood pressure medications (like ACE inhibitors or diuretics) ^[9][11].

Gastroprotection and Monitoring

• Gastroprotection: Mild stomach upset or indigestion is a common side effect of indomethacin ^[12]. Taking the medication with food can help reduce nausea, but it does not prevent severe complications like stomach ulcers or bleeding ^[13]. To reduce these risks, doctors often prescribe a daily proton-pump inhibitor (PPI)—a strong acid-reducing medication—for the duration of the trial ^[14]. This is a risk-based decision, so ask your clinician if you need one.
• Monitoring: The level of testing required depends on your risks and the trial’s length. Your doctor may ask you to check your blood pressure at home and may order blood tests to check your creatinine (a key marker of kidney function) ^[4]. Complete blood counts and liver tests may also be checked for longer trials or higher-risk patients.

To make the most of the trial, keep a simple daily diary tracking the time you take your dose, your background pain score, the number of severe exacerbations, and any side effects.

Emergency Warning Signs and When to Stop

Safety is the absolute priority. Never self-escalate your dose. Taking higher doses without supervision sharply increases the risk of ulcers, kidney toxicity, and cardiovascular events ^[4][10].

If you experience mild side effects, contact your doctor for advice on whether to adjust or stop the dose. However, stop the medication immediately and seek emergency medical care if you experience:

• Vomiting blood or material that looks like coffee grounds
• Black, tarry, or bloody stools
• Sudden chest pain, severe breathlessness, or facial/throat swelling
• Sudden weakness, severe confusion, or visual changes
• A severe drop in urine output
• Myoclonus (sudden, involuntary muscle jerking) or extreme agitation ^[10][15]

If you have to stop the trial early because of intolerance or side effects, it simply means the trial is inconclusive—it does not mean you definitely do not have hemicrania continua ^[16].

What Happens Next?

• If the trial is positive: Your pain stops completely. Because indomethacin carries long-term risks, your doctor will discuss whether to stay on a maintenance dose (using the lowest effective dose) ^[5], or transition to alternative preventive medications.
• If the trial is negative: If you reach the maximum safe dose without complete relief, your doctor will evaluate you for other headache disorders.
• If the trial is inconclusive: If side effects force you to stop before reaching a therapeutic dose, your doctor may evaluate alternative treatments or imaging.